Orthopedics competitors Stryker and Zimmer Biomet outlined two different approaches to growth in their latest earnings updates. Stryker CEO Kevin Lobo highlighted the company’s recent acquisitions on a Tuesday earnings call. Stryker has bought a total of seven companies so far this year and expects they will contribute $300 million to its sales in 2025, the CEO said. The acquisitions are small, for the most part, but “very exciting for each of those individual businesses,” Lobo said. Zimmer outlined a different approach in its earnings call on Wednesday morning.
Read the full article: Stryker, Zimmer Outline Different M&A Strategies //
Source: https://www.medtechdive.com/news/stryker-zimmer-acquisition-strategies-q3-earnings/731500